Sun Pharma Q4 consolidated net profit up 7% at Rs 13 billion

Drug major Sun Pharma on Friday posted around 7 per cent increase in consolidated net profit at Rs 13.08 billion for the quarter ended March on the back of revenue growth in India and emerging markets even as the US sales took a hit.

The company had reported a net profit of Rs 12.23 billion in the same period of the previous financial year.

The total revenue from operations declined to Rs 69.77 billion for the fourth quarter against Rs 71.36 billion during the same period of 2016-17.

For the year ended March 31, the drug major posted a net